Trial Profile
Non-interventional Study of Pomalidomide (Imnovid) in Combination With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Apr 2022
Price :
$35
*
At a glance
- Drugs Pomalidomide (Primary) ; Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms Poseidon
- 24 Feb 2021 Status changed from active, no longer recruiting to completed.
- 26 Apr 2017 Planned End Date changed from 1 Sep 2020 to 1 Mar 2021.
- 26 Apr 2017 Planned primary completion date changed from 1 Jul 2020 to 1 Mar 2021.